Influenza vaccination among children with idiopathic nephrotic syndrome: an investigation of practices.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
25 02 2019
Historique:
received: 20 09 2018
accepted: 30 01 2019
entrez: 27 2 2019
pubmed: 26 2 2019
medline: 7 3 2020
Statut: epublish

Résumé

Annual influenza vaccination is recommended for all children with idiopathic nephrotic syndrome (INS) in France. Consequently, the Social Security automatically sends prescriptions to all patients suffering from a chronic disease. The aim of this study was to evaluate the follow-up to these recommendations. We conducted a monocentric retrospective investigation of practices. We included all children with steroid-sensitive INS in remission who attended our clinics from January 1st 2015 to January 1st 2017, resided in France and had a valid phone number. Data were collected from May 2017 to June 2017 through a phone interview and review of clinical charts. 75 patients met the inclusion criteria. The parents of 57 children could be reached by phone and agreed to participate to the survey. 35/57 (61.4%) declared having received a prescription during the 2016-2017 campaign. Only 14 children (24.6%) were vaccinated. 17/43 (39.5%) parents of unvaccinated children had concerns about the safety of the vaccine, 16/43 (37.2%) were not aware of the recommendations, 5/43 (11.6%) had been recommended by their physician not to vaccinate their child, 3/43 (7%) forgot to have them vaccinated and 2/43 (4.6%) reported no reason. 13/43 (30%) unvaccinated children presented a relapse during the flu season - 2/13 during an influenza-like illness - whereas 1/14 (7%) immunized children presented a relapse during the six months of post-vaccination follow-up. Relapse rates were not increased in vaccinated children compared to unvaccinated children (p = 0.15), nor in the 6 months following vaccination compared to the 6 months prior (1/14 vs 5/14, p = 0.20). 1) < 2/3 patients were properly prescribed the recommended yearly influenza vaccination at our center 2) only 1/4 were vaccinated and most of their parents were misinformed. Physicians must be aware of this and should make every effort to better inform their patients on the risks of flu illness and the benefits and safety of the vaccination.

Sections du résumé

BACKGROUND
Annual influenza vaccination is recommended for all children with idiopathic nephrotic syndrome (INS) in France. Consequently, the Social Security automatically sends prescriptions to all patients suffering from a chronic disease. The aim of this study was to evaluate the follow-up to these recommendations.
METHODS
We conducted a monocentric retrospective investigation of practices. We included all children with steroid-sensitive INS in remission who attended our clinics from January 1st 2015 to January 1st 2017, resided in France and had a valid phone number. Data were collected from May 2017 to June 2017 through a phone interview and review of clinical charts.
RESULTS
75 patients met the inclusion criteria. The parents of 57 children could be reached by phone and agreed to participate to the survey. 35/57 (61.4%) declared having received a prescription during the 2016-2017 campaign. Only 14 children (24.6%) were vaccinated. 17/43 (39.5%) parents of unvaccinated children had concerns about the safety of the vaccine, 16/43 (37.2%) were not aware of the recommendations, 5/43 (11.6%) had been recommended by their physician not to vaccinate their child, 3/43 (7%) forgot to have them vaccinated and 2/43 (4.6%) reported no reason. 13/43 (30%) unvaccinated children presented a relapse during the flu season - 2/13 during an influenza-like illness - whereas 1/14 (7%) immunized children presented a relapse during the six months of post-vaccination follow-up. Relapse rates were not increased in vaccinated children compared to unvaccinated children (p = 0.15), nor in the 6 months following vaccination compared to the 6 months prior (1/14 vs 5/14, p = 0.20).
CONCLUSIONS
1) < 2/3 patients were properly prescribed the recommended yearly influenza vaccination at our center 2) only 1/4 were vaccinated and most of their parents were misinformed. Physicians must be aware of this and should make every effort to better inform their patients on the risks of flu illness and the benefits and safety of the vaccination.

Identifiants

pubmed: 30803442
doi: 10.1186/s12882-019-1240-2
pii: 10.1186/s12882-019-1240-2
pmc: PMC6388483
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

65

Références

Euro Surveill. 2013 Oct 31;18(44):
pubmed: 24176658
Vaccine. 2015 Jan 29;33(5):610-4
pubmed: 25545596
Pediatr Nephrol. 2008 Jul;23(7):1107-13
pubmed: 18324419
N Engl J Med. 2005 Dec 15;353(24):2559-67
pubmed: 16354892
JAMA. 2002 Jun 26;287(24):3245-8
pubmed: 12076221
Pediatr Nephrol. 2016 Dec;31(12):2299-2308
pubmed: 27778092
Postgrad Med. 1979 May;65(5):229-31, 234-6
pubmed: 432155
Vaccine. 2014 Mar 10;32(12):1394-7
pubmed: 24486348
N Engl J Med. 2011 Jan 13;364(2):97-9
pubmed: 21226573
J Infect Dis. 2015 May 15;211(10):1529-40
pubmed: 25406334
Pediatr Nephrol. 2004 Jan;19(1):57-60
pubmed: 14648340
Vaccine. 2013 Jul 18;31(33):3309-12
pubmed: 23684838
MMWR Morb Mortal Wkly Rep. 2018 Jun 08;67(22):634-642
pubmed: 29879098
N Engl J Med. 2014 Aug 14;371(7):635-45
pubmed: 25119609
Lancet. 2003 Aug 9;362(9382):449-50
pubmed: 12927434
JAMA. 1979 Oct 19;242(16):1752-4
pubmed: 480601
Vaccine. 2016 Sep 22;34(41):4948-4954
pubmed: 27576076
MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60
pubmed: 18685555
J Infect Dis. 2009 Jan 15;199(2):159-67
pubmed: 19086915
Lancet. 1998 Jan 31;351(9099):356-61
pubmed: 9652634
Arch Dis Child. 2007 Oct;92(10):887-9
pubmed: 17468130
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
Nephron. 1986;42(2):110-5
pubmed: 3484807
Pediatr Nephrol. 1989 Jan;3(1):101-10
pubmed: 2702078
Pediatr Nephrol. 2002 Mar;17(3):181-3
pubmed: 11956856
J Pediatr. 2018 May;196:217-222.e1
pubmed: 29499990
N Engl J Med. 2017 Aug 10;377(6):534-543
pubmed: 28792867
Pediatrics. 2017 May;139(5):
pubmed: 28557757
Vaccine. 2015 Sep 22;33(39):5181-7
pubmed: 26271827

Auteurs

Roman Klifa (R)

Néphrologie Pédiatrique, Centre de Référence du Syndrome Néphrotique Idiopathique de l'enfant et l'adulte, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Université Paris Descartes, Sorbonne paris Cité, 149 rue de Sèvres, 75015, Paris, France. klifaroman@msn.com.

Julie Toubiana (J)

Pédiatrie Générale et Infectieuse, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Université Paris Descartes, Sorbonne paris Cité, Paris, France.

Alizée Michel (A)

Néphrologie Pédiatrique, Centre de Référence du Syndrome Néphrotique Idiopathique de l'enfant et l'adulte, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Université Paris Descartes, Sorbonne paris Cité, 149 rue de Sèvres, 75015, Paris, France.

Nathalie Biebuyck (N)

Néphrologie Pédiatrique, Centre de Référence du Syndrome Néphrotique Idiopathique de l'enfant et l'adulte, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Université Paris Descartes, Sorbonne paris Cité, 149 rue de Sèvres, 75015, Paris, France.

Marina Charbit (M)

Néphrologie Pédiatrique, Centre de Référence du Syndrome Néphrotique Idiopathique de l'enfant et l'adulte, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Université Paris Descartes, Sorbonne paris Cité, 149 rue de Sèvres, 75015, Paris, France.

Laurence Heidet (L)

Néphrologie Pédiatrique, Centre de Référence du Syndrome Néphrotique Idiopathique de l'enfant et l'adulte, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Université Paris Descartes, Sorbonne paris Cité, 149 rue de Sèvres, 75015, Paris, France.

Saoussen Krid (S)

Néphrologie Pédiatrique, Centre de Référence du Syndrome Néphrotique Idiopathique de l'enfant et l'adulte, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Université Paris Descartes, Sorbonne paris Cité, 149 rue de Sèvres, 75015, Paris, France.

Pauline Krug (P)

Néphrologie Pédiatrique, Centre de Référence du Syndrome Néphrotique Idiopathique de l'enfant et l'adulte, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Université Paris Descartes, Sorbonne paris Cité, 149 rue de Sèvres, 75015, Paris, France.

Rémi Salomon (R)

Néphrologie Pédiatrique, Centre de Référence du Syndrome Néphrotique Idiopathique de l'enfant et l'adulte, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Université Paris Descartes, Sorbonne paris Cité, 149 rue de Sèvres, 75015, Paris, France.

Olivia Boyer (O)

Néphrologie Pédiatrique, Centre de Référence du Syndrome Néphrotique Idiopathique de l'enfant et l'adulte, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Université Paris Descartes, Sorbonne paris Cité, 149 rue de Sèvres, 75015, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH